The goal was never "stability" Buckland, it was to develop a medication that would slow the progress of this (MND's) aggressive progress. If one patient is showing apparent stability and it's proven to be caused by the monepantel treatment, then that was an unexpected bonus. Stop trolling.
- Forums
- ASX - By Stock
- Ann: PharmAust MND Trial Interim Analysis PK Outcomes
The goal was never "stability" Buckland, it was to develop a...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $89.95M |
Open | High | Low | Value | Volume |
18.5¢ | 19.0¢ | 18.5¢ | $36.60K | 197.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 40000 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 438565 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 155733 | 0.180 |
5 | 367819 | 0.175 |
6 | 465000 | 0.170 |
5 | 416607 | 0.165 |
12 | 575554 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 50000 | 1 |
0.190 | 438565 | 7 |
0.195 | 647804 | 11 |
0.200 | 217600 | 9 |
0.205 | 221875 | 2 |
Last trade - 10.59am 30/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |